Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Insulin_degludec> ?p ?o }
Showing triples 1 to 88 of
88
with 100 triples per page.
- Insulin_degludec abstract "Insulin degludec (INN/USAN) is an ultralong-acting basal insulin analogue that was developed by Novo Nordisk under the brand name Tresiba. It is administered via subcutaneous injection once daily to help control the blood sugar level of those with diabetes. It has a duration of action that lasts up to 42 hours (compared to 18 to 26 hours provided by other marketed long-acting insulins such as insulin glargine and insulin detemir), making it a once-daily basal insulin, that is one that provides a base insulin level, as opposed to the fast and short acting bolus insulins.Insulin degludec is a modified insulin that has one single amino acid deleted in comparison to human insulin, and is conjugated to hexadecanedioic acid via gamma-L-glutamyl spacer at the amino acid lysine at position B29.".
- Insulin_degludec atcPrefix "A10".
- Insulin_degludec atcSuffix "AE06".
- Insulin_degludec casNumber "844439-96-9".
- Insulin_degludec iupacName "B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin".
- Insulin_degludec wikiPageExternalLink dpdirect.jsp?name=Insulin+degludec.
- Insulin_degludec wikiPageExternalLink rd_pipeline.asp?showid=4.
- Insulin_degludec wikiPageID "29508560".
- Insulin_degludec wikiPageLength "11282".
- Insulin_degludec wikiPageOutDegree "28".
- Insulin_degludec wikiPageRevisionID "691441068".
- Insulin_degludec wikiPageWikiLink Basal_rate.
- Insulin_degludec wikiPageWikiLink Blood_sugar.
- Insulin_degludec wikiPageWikiLink Category:Human_proteins.
- Insulin_degludec wikiPageWikiLink Category:Insulin_therapies.
- Insulin_degludec wikiPageWikiLink Category:Peptide_hormones.
- Insulin_degludec wikiPageWikiLink Category:Recombinant_proteins.
- Insulin_degludec wikiPageWikiLink Diabetes_management.
- Insulin_degludec wikiPageWikiLink Diabetes_mellitus.
- Insulin_degludec wikiPageWikiLink Diabetes_mellitus_type_1.
- Insulin_degludec wikiPageWikiLink Diabetes_mellitus_type_2.
- Insulin_degludec wikiPageWikiLink Food_and_Drug_Administration.
- Insulin_degludec wikiPageWikiLink Glycated_hemoglobin.
- Insulin_degludec wikiPageWikiLink Hypoglycemia.
- Insulin_degludec wikiPageWikiLink Injection_(medicine).
- Insulin_degludec wikiPageWikiLink Insulin_analog.
- Insulin_degludec wikiPageWikiLink Insulin_aspart.
- Insulin_degludec wikiPageWikiLink Insulin_detemir.
- Insulin_degludec wikiPageWikiLink Insulin_glargine.
- Insulin_degludec wikiPageWikiLink International_nonproprietary_name.
- Insulin_degludec wikiPageWikiLink Lysine.
- Insulin_degludec wikiPageWikiLink Metformin.
- Insulin_degludec wikiPageWikiLink Novo_Nordisk.
- Insulin_degludec wikiPageWikiLink Pioglitazone.
- Insulin_degludec wikiPageWikiLink Subcutaneous_injection.
- Insulin_degludec wikiPageWikiLink United_States_Adopted_Name.
- Insulin_degludec wikiPageWikiLinkText "Degludec".
- Insulin_degludec wikiPageWikiLinkText "Insulin degludec".
- Insulin_degludec wikiPageWikiLinkText "degludec".
- Insulin_degludec wikiPageWikiLinkText "insulin degludec".
- Insulin_degludec atcPrefix "A10".
- Insulin_degludec atcSuffix "AE06".
- Insulin_degludec c "274".
- Insulin_degludec casNumber "844439".
- Insulin_degludec chemspiderid "none".
- Insulin_degludec h "411".
- Insulin_degludec iupacName "B29N-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin".
- Insulin_degludec kegg "D09727".
- Insulin_degludec legalStatus "Rx-only".
- Insulin_degludec molecularWeight "6103.972".
- Insulin_degludec n "65".
- Insulin_degludec o "81".
- Insulin_degludec pubchemsubstance "124490467".
- Insulin_degludec routesOfAdministration "Subcutaneous".
- Insulin_degludec s "6".
- Insulin_degludec tradename "Tresiba".
- Insulin_degludec verifiedrevid "476995027".
- Insulin_degludec watchedfields "changed".
- Insulin_degludec wikiPageUsesTemplate Template:Chemspidercite.
- Insulin_degludec wikiPageUsesTemplate Template:Drugbox.
- Insulin_degludec wikiPageUsesTemplate Template:Drugs.com.
- Insulin_degludec wikiPageUsesTemplate Template:Oral_hypoglycemics_and_insulin_analogs.
- Insulin_degludec wikiPageUsesTemplate Template:Peptidergics.
- Insulin_degludec wikiPageUsesTemplate Template:Reflist.
- Insulin_degludec subject Category:Human_proteins.
- Insulin_degludec subject Category:Insulin_therapies.
- Insulin_degludec subject Category:Peptide_hormones.
- Insulin_degludec subject Category:Recombinant_proteins.
- Insulin_degludec hypernym Analogue.
- Insulin_degludec type ChemicalSubstance.
- Insulin_degludec type Drug.
- Insulin_degludec type Chemical.
- Insulin_degludec type Drug.
- Insulin_degludec type Hormone.
- Insulin_degludec type Peptide.
- Insulin_degludec type Product.
- Insulin_degludec type Redirect.
- Insulin_degludec type ChemicalObject.
- Insulin_degludec type Thing.
- Insulin_degludec type Q8386.
- Insulin_degludec comment "Insulin degludec (INN/USAN) is an ultralong-acting basal insulin analogue that was developed by Novo Nordisk under the brand name Tresiba. It is administered via subcutaneous injection once daily to help control the blood sugar level of those with diabetes.".
- Insulin_degludec label "Insulin degludec".
- Insulin_degludec sameAs Q16252338.
- Insulin_degludec sameAs إنسولين_ديجلوديك.
- Insulin_degludec sameAs m.0dsdg4x.
- Insulin_degludec sameAs Q16252338.
- Insulin_degludec wasDerivedFrom Insulin_degludec?oldid=691441068.
- Insulin_degludec isPrimaryTopicOf Insulin_degludec.